CASE CCC IN THE NEWS
Salon Group Targets Tanning 'Myths'
ABC News - Jan 6, 2013
... they say it, according to Cleveland dermatologist Kevin Cooper, MD. ... and that is simply untrue," said Cooper, of Case Western Reserve ...
Secretary of State Clinton Remains Hospitalized for Blood Clot
MSNBC - Dec 31, 2012
Dr. Alvin Schmaier, hematologist with UH Case Medical Center, discusses blood clot dangers, and why Secretary Clinton may be at risk and how ...
Woman's Faith and Love of Family Help her Overcome Cancer
The Vindicator - Dec 23, 2012
Sometimes that is the only option, said Dr. Samuel T. Chaoof the Cleveland Clinic's Brain Tumor and Neuro-oncology Center and Radiation Oncology Department...
Novel Assay Shows Promise in Heparin-induced Thrombocytopenia
Helio/HemOnc Today - Dec 21, 2012
Perspective commentary by Keith McCrae...This is an important study. Heparin-induced thrombocytopenia (HIT) is another major concern of hematologists...
Researcher Spotlights Changes in Treatment of ALL
Helio/HemOnc Today - Dec 20, 2012 (video)
Matt Kalaycio, MD, director of the Bone Marrow Transplant Program at Taussig Cancer Institute at Cleveland Clinic, reacts to the findings of two studies that addressed the role of autologous vs. allogeneic transplantation in patients with acute lymphoblastic leukemia.
Fibulin-3 Biomarker May Detect Early-stage Pleural Mesothelioma
Helio/HemOnc Today - Dec 18, 2012
Perspective commentary by James P. Stevenson... This study is important in that it describes the first highly-sensitive and specific plasma and pleural effusion biomarker for pleural mesothelioma...
Kurt Stange To Lead Patient-Centered Outcomes Research Institute Research Project
Dr. Kurt Stange will lead a project funded by the Patient-Centered Outcomes Research Institute. The project will compare how focusing on patient strengths and patient-centered treatment can enhance patient health care and well-being as opposed to the usual model of focusing on the patient's symptoms, limitations and weaknesses. The project is part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda. [more]
Seidman Cancer Center Clinical Trials Unit Celebrate New Office Space
The University Hospitals Seidman Cancer Center (SCC) recently sponsored an open house event to celebrate the grand opening of new offices for the Clinical Trials Unit (CTU). The administrative offices of the SCC CTU have been relocated to the Fenway Manor building on the corner of Stokes Boulevard and Euclid Avenue.
This refurbished physical space consists of more than 6000 square feet, and brings together more than 50 employees who were previously dispersed. As Case CCC Associate Director for Clinical Research Dr. Neal Meropol notes, "The open style of architecture of this state-of-the-art facility was designed to encourage a high level of interaction and teamwork. I'm especially fond of the comfortable window seat for informal meetings." The newly redesigned space includes office and meeting space, and research chart storage space on site for the administrative, management, regulatory, data and clinical staff. The new offices will supplement our existing clinical and administrative space in the Seidman Cancer Hospital.
Parking is available at the Walker Building, across the street from new location. Access to the building is provided through the main entrance to Fenway Manor on Stokes Blvd. and contacting the research staff via the intercom system, or by directly contacting Melissa Kadar, Director Clinical Trials Unit.
CTSC Core Utilization Awards
Congratulations to the recipients of the September and October CTSC Core Utilization Awards (Case CCC members indicated in bold):
- Mukesh Jain, MD: Circadian regulation of cardiac response to stress: a transcriptome study of cardiac KLF15 null mice
- Neelesh Sharma, MD, PhD: Microarray gene expression analyses to identify pharmacodynamic marker of erlotinib and quinacrine in non-small cell lung cancer (NSCLC)
- Erica Campagnaro, MD: Oncology Nurses' Barriers to Discussion of Clinical Trial Therapy with Cancer Patients - Qualitative Analyses and Instrument Development
- Donna Hansel, MD, PhD: Development of a Bladder Cancer Urine Biomarker Core Utilization Pilot Grant
- David Kennedy, PhD: Paraoxonases in Cardio-Renal Syndrome
- Derek Taylor, PhD: Promoting cancer cell death by selective induction of telomere instability
- Lance Vernon, DMD, MPH: Immune and Inflammatory Consequences of Intensive Periodontal Disease Treatment in HIV+ Adults
Children's Tumor Foundation Young Investigator Award
The Children's Tumor Foundation is proud to announce the launch of the 2013 Young Investigator Award (YIA) application process. The Foundation's longest running program, YIA provides two-year awards for young scientists early in their careers, bringing them into the NF field and helping to establish them as independent investigators.
Pre-Application Deadline: January 25
Application Deadline: March 15
American Cancer Society IRG Awards
The Case CCC, with funds from its American Cancer Society Institutional Research Grant, will provide seed money to foster cancer research by junior faculty who have no current national grant support of their own. Investigators in the CWRU School of Medicine and Cleveland Clinic Lerner College of Medicine as well as in other schools and colleges in the University are eligible. Grants, not to exceed $30,000, will be awarded to investigators who intend to gather preliminary data to be used in seeking future and independently funded programs.
LOI Deadline: February 18
Application Deadline: April 5
MARK YOUR CALENDARS
OnCore Clinical Trials Management System Training Classes
OnCore training classes will be held quarterly at 12 pm in Wearn 137. Each class will cover a different topic in the OnCore database, with the last 15-20 minutes of each class open to answer specific questions. Participation is open and encouraged for anyone new or old to OnCore. Please feel free to bring your lunch. Webinar instructions will be sent prior to the class for those that cannot attend in person. One-on-one training sessions are also available as needed.
Schedule of sessions:
- January 16, 2013: What We Learned About Missing Info in OnCore Needed for the Grant Renewal and NCI Site Visit (Including changes to the PRMC application)
- April 17, 2013: Important Fields Needed for Clinicaltrials.gov and NCI/CTRP Registration (Including changes to the PRMC application)
- July 17, 2013: Important Fields Needed for Clinicaltrials.gov Results Reporting
- Oct 16, 2013: OnCore and CIRB Studies
Please contact April Firstencel at 216.286.2294 or email@example.com with any questions.
Prostate Cancer Symposium
The Glickman Urological & Kidney Institute, Lerner Research Institute, and Case Comprehensive Cancer Center invite you to a symposium on The Role of Interferon in Metastasis and Resistance to DNA Damage in Prostate Cancer, February 7in Cleveland Clinic Room Q1-300. Registration information will be posted soon.